{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:39:09Z","timestamp":1793799549385,"version":"4.6.1"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board, department of science and technology, New Delhi, India","doi-asserted-by":"publisher","award":["CRG\/2021\/005540"],"award-info":[{"award-number":["CRG\/2021\/005540"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Skin cancer, including basal cell carcinoma, melanoma, and squamous cell carcinoma, is conventionally treated by surgery, phototherapy, immunotherapy, and chemotherapy. For decades, surgical removal of malignant cancers has favored patients' therapeutic options. However, multiple aspects, such as the patient's comorbidities, the anatomical location of the lesion, and possible resistance to recurrent excisions, can influence the decision to conduct surgery. Therefore, topical and transdermal therapy may be a more appropriate option, allowing for higher therapeutic levels at the site of action and reducing toxicity than systemic therapy. The most commonly used topical agents for treating skin carcinoma are- 5-fluorouracil, imiquimod, sonidegib, dacarbazine, etc. However, drug physicochemical characteristics and skin physiological barriers limit the anticancer potency of topical as well as transdermal drug delivery. In recent years, unquestionable signs of progress have been demonstrated to circumvent these challenges. In particular, significant studies have been made, including modification of bio-actives, permeability enhancers, incorporation of advanced nano and microcarriers, and physical enhancement devices. This critical review summarizes the advancement in the chemical composition of bioactives used in skin cancer, such as sinecatechins, BIL-010t, patidegib, gingerol, curcumin, remetinostat, epigallocatechin-3-gallate, etc. Furthermore, this review, specifically addresses the progress in transdermal delivery systems for melanoma and non-melanoma cancer therapy, emphasizing advances in physical and chemical penetration enhancement and nanocarrier-assisted transdermal systems.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026622666220902104906","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T12:45:26Z","timestamp":1662209126000},"page":"31-43","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recent Advances in Chemical Composition and Transdermal Delivery\nSystems for Topical Bio-actives in Skin Cancer"],"prefix":"10.2174","volume":"23","author":[{"given":"Goutam","family":"Rath","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Science, Siksha \u2018O\u2019 Anusandhan (Deemed to be University), Bhubaneswar, Odisha, \n751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitu","family":"Halder","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Siksha \u2018O\u2019 Anusandhan (Deemed to be University), Bhubaneswar, Odisha, \n751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Mishra","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Siksha \u2018O\u2019 Anusandhan (Deemed to be University), Bhubaneswar, Odisha, \n751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswakanth","family":"Kar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Siksha \u2018O\u2019 Anusandhan (Deemed to be University), Bhubaneswar, Odisha, \n751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Ghosh","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Siksha \u2018O\u2019 Anusandhan (Deemed to be University), Bhubaneswar, Odisha, \n751003, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Cancer Statistics U.S. Department of Health and Human ServicesAvailable from:  (Accessed on:Aug 12, 2021).","journal-title":"Cancer Statistics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijwd.2021.01.017","volume":"7","author":"Davis D.S.","year":"2021","unstructured":"Davis D.S.; Robinson C.; Callender V.D.; Skin cancer in women of color: Epidemiology, pathogenesis and clinical manifestations. Int J Womens Dermatol 2021,7(2),127-134","journal-title":"Int J Womens Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","volume":"15","author":"Harms P.W.","year":"2018","unstructured":"Harms P.W.; Harms K.L.; Moore P.S.; DeCaprio J.A.; Nghiem P.; Wong M.K.K.; Brownell I.; The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol 2018,15(12),763-776","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1586\/era.10.154","volume":"10","author":"Zhao B.","year":"2010","unstructured":"Zhao B.; He Y.Y.; Recent advances in the prevention and treatment of skin cancer using photodynamic therapy. Expert Rev Anticancer Ther 2010,10(11),1797-1809","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.addr.2019.11.002","volume":"153","author":"Cullen J.K.","year":"2020","unstructured":"Cullen J.K.; Simmons J.L.; Parsons P.G.; Boyle G.M.; Topical treatments for skin cancer. Adv Drug Deliv Rev 2020,153,54-64","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e9211","DOI":"10.7759\/cureus.9211","volume":"12","author":"Quazi S.J.","year":"2020","unstructured":"Quazi S.J.; Aslam N.; Saleem H.; Rahman J.; Khan S.; Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020,12(7),e9211","journal-title":"Cureus"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13643-020-01350-5","volume":"9","author":"Nolan G.S.","year":"2020","unstructured":"Nolan G.S.; Wormald J.C.R.; Kiely A.L.; Totty J.P.; Jain A.; Global incidence of incomplete surgical excision in adult patients with non-melanoma skin cancer: study protocol for a systematic review and meta-analysis of observational studies. Syst Rev 2020,9(1),83","journal-title":"Syst Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"S0190962221007726","DOI":"10.1016\/j.jaad.2021.02.091","author":"Adalsteinsson J.A.","year":"2021","unstructured":"Adalsteinsson J.A.; Stoj V.J.; Algzlan H.; Swede H.; Torbeck R.L.; Ratner D.; Limitations in the literature regarding Mohs surgery and staged excision for melanoma: A critical review of quality and data reporting. J Am Acad Dermatol [Epub Ahead of Print].2021,S0190962221007726","journal-title":"J Am Acad Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"Prausnitz M.R.","year":"2008","unstructured":"Prausnitz M.R.; Langer R.; Transdermal drug delivery. Nat Biotechnol 2008,26(11),1261-1268","journal-title":"Nat Biotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/978-3-642-00477-3_13","volume":"197","author":"Guy R.H.","year":"2010","unstructured":"Guy R.H.; Transdermal Drug Delivery. Sch&#xE4;fer-Korting, M, Ed Drug Delivery Handbook of Experimental Pharmacology Springer Berlin Heidelberg: Berlin, Heidelberg 2010,197,399-410","journal-title":"Sch&#xE4;fer-Korting, M, Ed Drug Delivery Handbook of Experimental Pharmacology Springer Berlin Heidelberg: Berlin, Heidelberg"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00042728-200704000-00008","volume":"33","author":"Gross K.","year":"2007","unstructured":"Gross K.; Kircik L.; Kricorian G.; 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007,33(4),433-440","journal-title":"Dermatol Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.det.2004.08.007","volume":"23","author":"Burns C.A.","year":"2005","unstructured":"Burns C.A.; Brown M.D.; Imiquimod for the treatment of skin cancer. Dermatol Clin 2005,23(1),151-164","journal-title":"Dermatol Clin"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000488248","volume":"31","author":"Schmitz L.","year":"2018","unstructured":"Schmitz L.; Gupta G.; Segert M.H.; Kost R.; Sternberg J.; Gambichler T.; Stockfleth E.; Dirschka T.; Diclofenac sodium 3% in hyaluronic acid 2.5% gel significantly diminishes the actinic keratosis area and severity index. Skin Pharmacol Physiol 2018,31(4),206-211","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/dth.12399","volume":"29","author":"Izzi S.","year":"2016","unstructured":"Izzi S.; Sorgi P.; Piemonte P.; Carbone A.; Frascione P.; Successfully treated superficial basal cell carcinomas with ingenol mebutate 0.05% gel: Report of twenty cases. Dermatol Ther 2016,29(6),470-472","journal-title":"Dermatol Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejps.2015.06.013","volume":"77","author":"Haque T.","year":"2015","unstructured":"Haque T.; Rahman K.M.; Thurston D.E.; Hadgraft J.; Lane M.E.; Topical therapies for skin cancer and actinic keratosis. Eur J Pharm Sci 2015,77,279-289","journal-title":"Eur J Pharm Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e08938","DOI":"10.1016\/j.heliyon.2022.e08938","volume":"8","author":"Souto E.B.","year":"2022","unstructured":"Souto E.B.; Fangueiro J.F.; Fernandes A.R.; Cano A.; Sanchez-Lopez E.; Garcia M.L.; Severino P.; Paganelli M.O.; Chaud M.V.; Silva A.M.; Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon 2022,8(2),e08938","journal-title":"Heliyon"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"15816","DOI":"10.1073\/pnas.1016152108","volume":"108","author":"Hsu T.","year":"2011","unstructured":"Hsu T.; Mitragotri S.; Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc Natl Acad Sci USA 2011,108(38),15816-15821","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI89820","volume":"127","author":"Cunningham T.J.","year":"2016","unstructured":"Cunningham T.J.; Tabacchi M.; Eliane J.P.; Tuchayi S.M.; Manivasagam S.; Mirzaalian H.; Turkoz A.; Kopan R.; Schaffer A.; Saavedra A.P.; Wallendorf M.; Cornelius L.A.; Demehri S.; Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. J Clin Invest 2016,127(1),106-116","journal-title":"J Clin Invest"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00128071-200102020-00008","volume":"2","author":"Scott L.J.","year":"2001","unstructured":"Scott L.J.; Dunn C.J.; Goa K.L.; Calcipotriol ointment. Am J Clin Dermatol 2001,2(2),95-120","journal-title":"Am J Clin Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3390\/molecules25143146","volume":"25","author":"Almatroodi S.A.","year":"2020","unstructured":"Almatroodi S.A.; Almatroudi A.; Khan A.A.; Alhumaydhi F.A.; Alsahli M.A.; Rahmani A.H.; Potential therapeutic targets of Epigallocatechin Gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer. Molecules 2020,25(14),3146","journal-title":"Molecules"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3109\/10717544.2014.935532","volume":"23","author":"Marwah H.","year":"2016","unstructured":"Marwah H.; Garg T.; Goyal A.K.; Rath G.; Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 2016,23(2),564-578","journal-title":"Drug Deliv"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2020.04.008","volume":"153","author":"Yamada M.","year":"2020","unstructured":"Yamada M.; Prow T.W.; Physical drug delivery enhancement for aged skin, UV damaged skin and skin cancer: Translation and commercialization. Adv Drug Deliv Rev 2020,153,2-17","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/s2175-97902018000001008","volume":"54","author":"Petrilli R.","year":"2018","unstructured":"Petrilli R.; Lopez R.F.V.; Physical methods for topical skin drug delivery: concepts and applications. Braz J Pharm Sci 2018,54(spe),54","journal-title":"Braz J Pharm Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41598-018-19463-2","volume":"8","author":"Pan J.","year":"2018","unstructured":"Pan J.; Ruan W.; Qin M.; Long Y.; Wan T.; Yu K.; Zhai Y.; Wu C.; Xu Y.; Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Sci Rep 2018,8(1),1117","journal-title":"Sci Rep"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1166\/jnn.2019.15884","volume":"19","author":"Tian Z.","year":"2019","unstructured":"Tian Z.; Cheng J.; Liu J.; Zhu Y.; Dissolving graphene\/poly(Acrylic Acid) microneedles for potential transdermal drug delivery and photothermal therapy. J Nanosci Nanotechnol 2019,19,2453-2459","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/156720112800234585","volume":"9","author":"Parhi R.","year":"2012","unstructured":"Parhi R.; Suresh P.; Mondal S.; Mahesh Kumar P.; Novel penetration enhancers for skin applications: a review. Curr Drug Deliv 2012,9(2),219-230","journal-title":"Curr Drug Deliv"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2606271","DOI":"10.1155\/2017\/2606271","volume":"2017","author":"Orthaber K.","year":"2017","unstructured":"Orthaber K.; Pristovnik M.; Skok K.; Peri\u0107 B.; Maver U.; Skin cancer and its treatment: novel treatment approaches with emphasis on nanotechnology. J Nanomater 2017,2017,2606271","journal-title":"J Nanomater"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2016.03.010","volume":"228","author":"Dorrani M.","year":"2016","unstructured":"Dorrani M.; Garbuzenko O.B.; Minko T.; Michniak K.B.; Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J Control Release 2016,228,150-158","journal-title":"J Control Release"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1166\/jbn.2015.1999","volume":"11","author":"Choi B.B.","year":"2015","unstructured":"Choi B.B.; Kim M.S.; Song K.W.; Kim U.K.; Hong J.W.; Lee H.J.; Kim G.C.; Targeting NEU protein in melanoma cells with non-thermal atmospheric pressure plasma and gold nanoparticles. J Biomed Nanotechnol 2015,11,900-905","journal-title":"J Biomed Nanotechnol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/smll.201400775","volume":"11","author":"Rao Y.","year":"2015","unstructured":"Rao Y.; Chen W.; Liang X.; Huang Y.; Miao J.; Liu L.; Lou Y.; Zhang X.; Wang B.; Tang R.; Chen Z.; Lu X.; Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier. Small 2015,11(2),239-247","journal-title":"Small"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/lsm.20968","volume":"42","author":"Huang N.","year":"2010","unstructured":"Huang N.; Wang H.; Zhao J.; Lui H.; Korbelik M.; Zeng H.; Single-wall carbon nanotubes assisted photothermal cancer therapy: Animal study with a murine model of squamous cell carcinoma. Lasers Surg Med 2010,42(9),798-808","journal-title":"Lasers Surg Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1039\/C4NR05241B","volume":"7","author":"Venuganti V.V.K.","year":"2015","unstructured":"Venuganti V.V.K.; Saraswathy M.; Dwivedi C.; Kaushik R.S.; Perumal O.P.; Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model. Nanoscale 2015,7(9),3903-3914","journal-title":"Nanoscale"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1872210513666190314095643","volume":"13","author":"Patel G.","year":"2019","unstructured":"Patel G.; Yadav B.K.N.; Formulation, characterization and in vitro cytotoxicity of 5-fluorouracil loaded polymeric electrospun nanofibers for the treatment of skin cancer. Recent Pat Nanotechnol 2019,13(2),114-128","journal-title":"Recent Pat Nanotechnol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"103120","DOI":"10.1016\/j.arabjc.2021.103120","volume":"14","author":"Nazir S.","year":"2021","unstructured":"Nazir S.; Umar Aslam Khan M.; Shamsan Al-Arjan W.; Izwan Abd Razak S.; Javed A.; Rafiq Abdul Kadir M.; Nanocomposite hydrogels for melanoma skin cancer care and treatment: In-vitro drug delivery, drug release kinetics and anti-cancer activities. Arab J Chem 2021,14(5),103120","journal-title":"Arab J Chem"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1166\/jbn.2015.2139","volume":"11","author":"Huber L.A.","year":"2015","unstructured":"Huber L.A.; Pereira T.A.; Ramos D.N.; Rezende L.C.D.; Emery F.S.; Sobral L.M.; Leopoldino A.M.; Lopez R.F.V.; Topical skin cancer therapy using doxorubicin-loaded cationic lipid nanoparticles and iontophoresis. J Biomed Nanotechnol 2015,11,1975-1988","journal-title":"J Biomed Nanotechnol"},{"key":"ref=36","first-page":"1489","volume":"7","author":"Vannucci L.","year":"2012","unstructured":"Vannucci L.; Falvo E.; Fornara M.; Micco P.D.; Benada O.; Krizan J.; Svoboda J.; Hulikova C.K.; Morea V.; Boffi A.; Ceci P.; Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. Int J Nanomed 2012,7,1489-509","journal-title":"Int J Nanomed"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/02652048.2019.1701114","volume":"37","author":"Soni K.","year":"2020","unstructured":"Soni K.; Mujtaba A.; Akhter M.H.; Zafar A.; Kohli K.; Optimisation of ethosomal nanogel for topical nano-CUR and sulphoraphane delivery in effective skin cancer therapy. J Microencapsul 2020,37(2),91-108","journal-title":"J Microencapsul"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bioactmat.2020.04.002","volume":"5","author":"Hao Y.","year":"2020","unstructured":"Hao Y.; Chen Y.; He X.; Yang F.; Han R.; Yang C.; Li W.; Qian Z.; Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy. Bioact Mater 2020,5(3),542-552","journal-title":"Bioact Mater"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","volume":"3","author":"Naik A.","year":"2000","unstructured":"Naik A.; Kalia Y.N.; Guy R.H.; Transdermal drug delivery: overcoming the skin\u2019s barrier function. Pharm Sci Technol Today 2000,3(9),318-326","journal-title":"Pharm Sci Technol Today"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/emj.2005.027847","volume":"23","author":"Driscoll P.","year":"2006","unstructured":"Driscoll P.; Gray\u2019s Anatomy, 39th Edition. Emerg Med J 2006,23,492-492","journal-title":"Emerg Med J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/1523-1747.ep12319741","volume":"93","author":"De Rigal J.","year":"1989","unstructured":"De Rigal J.; Escoffier C.; Querleux B.; Faivre B.; Agache P.; L&#xE9;v&#xEA;que J.L.; Assessment of aging of the human skin by in vivo ultrasonic imaging. J Invest Dermatol 1989,93(5),621-625","journal-title":"J Invest Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.medengphy.2007.12.007","volume":"30","author":"Petrofsky J.S.","year":"2008","unstructured":"Petrofsky J.S.; Suh H.J.; Gunda S.; Prowse M.; Batt J.; Interrelationships between body fat and skin blood flow and the current required for electrical stimulation of human muscle. Med Eng Phys 2008,30(7),931-936","journal-title":"Med Eng Phys"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00276-002-0034-5","volume":"24","year":"2002","unstructured":"Y, L.; K, H. Skin thickness of Korean adults. Surg Radiol Anat 2002,24(3-4),183-189","journal-title":"Surg Radiol Anat"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000360009","volume":"28","author":"Sahle F.F.","year":"2015","unstructured":"Sahle F.F.; Gebre-Mariam T.; Dobner B.; Wohlrab J.; Neubert R.H.H.; Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol 2015,28(1),42-55","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=45","author":"Yousef H.","year":"2022","unstructured":"Yousef H.; Alhajj M.; Sharma S.;  Anatomy, skin (Integument), Epidermis 2022","journal-title":"Anatomy, skin (Integument), Epidermis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0169-409X(02)00121-7","volume":"54","author":"Menon G.K.","year":"2002","unstructured":"Menon G.K.; New insights into skin structure: scratching the surface. Adv Drug Deliv Rev 2002,54(Suppl. 1),S3-S17","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e974451","DOI":"10.4161\/21688370.2014.974451","volume":"3","author":"Brandner J.M.","year":"2015","unstructured":"Brandner J.M.; Zorn K.M.; Yoshida T.; Moll I.; Beck L.A.; De Benedetto A.; Epidermal tight junctions in health and disease. Tissue Barriers 2015,3(1-2),e974451","journal-title":"Tissue Barriers"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","volume":"7","author":"Alkilani A.","year":"2015","unstructured":"Alkilani A.; McCrudden M.T.; Donnelly R.; Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015,7(4),438-470","journal-title":"Pharmaceutics"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.mpmed.2013.04.017","volume":"41","author":"Lai-Cheong J.E.","year":"2013","unstructured":"Lai-Cheong J.E.; McGrath J.A.; Structure and function of skin, hair and nails. Medicine 2013,41(6),317-320","journal-title":"Medicine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jconrel.2016.07.027","volume":"242","author":"Vogt A.","year":"2016","unstructured":"Vogt A.; Wischke C.; Neffe A.T.; Ma N.; Alexiev U.; Lendlein A.; Nanocarriers for drug delivery into and through the skin \u2014 Do existing technologies match clinical challenges? J Control Release 2016,242,3-15","journal-title":"J Control Release"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.mpsur.2011.06.010","volume":"29","author":"Venus M.","year":"2011","unstructured":"Venus M.; Waterman J.; McNab I.; Basic physiology of the skin. Surgery 2011,29(10),471-474","journal-title":"Surgery"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"646554","DOI":"10.3389\/fbioe.2021.646554","volume":"9","author":"Yu Y.Q.","year":"2021","unstructured":"Yu Y.Q.; Yang X.; Wu X.F.; Fan Y.B.; Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front Bioeng Biotechnol 2021,9,646554","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"Bos J.D.","year":"2000","unstructured":"Bos J.D.; Meinardi M.M.H.M.; The 500 dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000,9(3),165-169","journal-title":"Exp Dermatol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"102437","DOI":"10.1016\/j.cis.2021.102437","volume":"293","author":"Salvioni L.","year":"2021","unstructured":"Salvioni L.; Morelli L.; Ochoa E.; Labra M.; Fiandra L.; Palugan L.; Prosperi D.; Colombo M.; The emerging role of nanotechnology in skincare. Adv Colloid Interface Sci 2021,293,102437","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=55","first-page":"p. 1","author":"Jain S.K.","year":"2016","unstructured":"Jain S.K.; Verma A.; Jain A.; Hurkat P.; Transfollicular drug delivery: current perspectives. Research and Reports. In: Transdermal Drug Delivery RRTD 2016,p. 1-17","journal-title":"In: Transdermal Drug Delivery RRTD"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12272-010-0301-7","volume":"33","author":"Subedi R.K.","year":"2010","unstructured":"Subedi R.K.; Oh S.Y.; Chun M.K.; Choi H.K.; Recent advances in transdermal drug delivery. Arch Pharm Res 2010,33(3),339-351","journal-title":"Arch Pharm Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/pharmaceutics13070960","volume":"13","author":"Neupane R.","year":"2021","unstructured":"Neupane R.; Boddu S.H.S.; Abou D.M.S.; Bachu R.D.; Terrero D.; Babu R.J.; Tiwari A.K.; Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities. Pharmaceutics 2021,13(7),960","journal-title":"Pharmaceutics"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ddr.430130209","volume":"13","author":"Flynn G.L.","year":"1988","unstructured":"Flynn G.L.; Stewart B.; Percutaneous drug penetration: Choosing candidates for transdermal development. Drug Dev Res 1988,13(2-3),169-185","journal-title":"Drug Dev Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-21-0560","volume":"27","author":"Kilgour J.M.","year":"2021","unstructured":"Kilgour J.M.; Shah A.; Urman N.M.; Eichstadt S.; Do H.N.; Bailey I.; Mirza A.; Li S.; Oro A.E.; Aasi S.Z.; Sarin K.Y.; Phase I.I.; Phase II open-label, single-arm trial to investigate the efficacy and safety of topical remetinostat gel in patients with basal cell carcinoma. Clin Cancer Res 2021,27(17),4717-4725","journal-title":"Clin Cancer Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jamadermatol.2019.1541","volume":"155","author":"Sohn G.K.","year":"2019","unstructured":"Sohn G.K.; Kwon G.P.; Bailey H.I.; Mirza A.; Sarin K.; Oro A.; Tang J.Y.; Topical itraconazole for the treatment of basal cell carcinoma in patients with basal cell nevus syndrome or high-frequency basal cell carcinomas. JAMA Dermatol 2019,155(9),1078-1080","journal-title":"JAMA Dermatol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bjd.15364","volume":"177","author":"Gilbert S.M.","year":"2017","unstructured":"Gilbert S.M.; Gidley Baird A.; Glazer S.; Barden J.A.; Glazer A.; Teh L.C.; King J.; A phase I clinical trial demonstrates that nfP2X 7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma. Br J Dermatol 2017,177(1),117-124","journal-title":"Br J Dermatol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jamadermatol.2017.2529","volume":"153","author":"Kessels J.","year":"2017","unstructured":"Kessels J.; Voeten L.; Nelemans P.; Cleutjens J.; Hillen L.M.; Mosterd K.; Kelleners-Smeets N.W.J.; Topical sinecatechins, 10%, Ointment for superficial basal cell carcinoma. JAMA Dermatol 2017,153(10),1061-1063","journal-title":"JAMA Dermatol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"582866","DOI":"10.3389\/fonc.2020.582866","volume":"10","author":"Brancaccio G.","year":"2020","unstructured":"Brancaccio G.; Pea F.; Moscarella E.; Argenziano G.; Sonidegib for the treatment of advanced basal cell carcinoma. Front Oncol 2020,10,582866","journal-title":"Front Oncol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3835(98)00081-0","volume":"129","author":"Park K.K.","year":"1998","unstructured":"Park K.K.; Chun K.S.; Lee J.M.; Lee S.S.; Surh Y.J.; Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett 1998,129(2),139-144","journal-title":"Cancer Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3892\/or.2015.4413","volume":"35","author":"Zhao G.","year":"2016","unstructured":"Zhao G.; Han X.; Zheng S.; Li Z.; Sha Y.; Ni J.; Sun Z.; Qiao S.; Song Z.; Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT\/mTOR signaling pathway in human melanoma cells. Oncol Rep 2016,35(2),1065-1074","journal-title":"Oncol Rep"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"12455","DOI":"10.1073\/pnas.182429899","volume":"99","author":"Lu Y.P.","year":"2002","unstructured":"Lu Y.P.; Lou Y.R.; Xie J.G.; Peng Q.Y.; Liao J.; Yang C.S.; Huang M.T.; Conney A.H.; Topical applications of caffeine or (\u2212)-Epigallocatechin Gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 2002,99(19),12455-12460","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1610-0387.2008.06865.x","volume":"7","author":"Huyke C.","year":"2009","unstructured":"Huyke C.; Reuter J.; R&#xF6;dig M.; Kersten A.; Laszczyk M.; Scheffler A.; Nashan D.; Schempp C.; Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. J Dtsch Dermatol Ges 2009,7(2),128-133","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.xphs.2020.12.024","volume":"110","author":"Zhang D.","year":"2021","unstructured":"Zhang D.; Wang W.; Hou T.; Pang Y.; Wang C.; Wu S.; Wang Q.; New delivery route of gambogic acid via skin for topical targeted therapy of cutaneous melanoma and reduction of systemic toxicity. J Pharm Sci 2021,110(5),2167-2176","journal-title":"J Pharm Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1517\/14712598.2014.913564","volume":"14","author":"Stockfleth E.","year":"2014","unstructured":"Stockfleth E.; Meyer T.; Sinecatechins (Polyphenon E) ointment for treatment of external genital warts and possible future indications. Expert Opin Biol Ther 2014,14(7),1033-1043","journal-title":"Expert Opin Biol Ther"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jnutbio.2012.03.009","volume":"24","author":"Lee I.T.","year":"2013","unstructured":"Lee I.T.; Lin C.C.; Lee C.Y.; Hsieh P.W.; Yang C.M.; Protective effects of (\u2212)-epigallocatechin-3-gallate against TNF-&#x3B1;-induced lung inflammation via ROS-dependent ICAM-1 inhibition. J Nutr Biochem 2013,24(1),124-136","journal-title":"J Nutr Biochem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.sajb.2019.06.006","volume":"124","author":"Bharadwaj R.","year":"2019","unstructured":"Bharadwaj R.; Haloi J.; Medhi S.; Topical delivery of methanolic root extract of Annona reticulata against skin cancer. S Afr J Bot 2019,124,484-493","journal-title":"S Afr J Bot"},{"key":"ref=72","first-page":"B9780128229606000000","author":"Mokoala K.M.G.","year":"2021","unstructured":"Mokoala K.M.G.; Lawal I.O.; Vorster M.; Sathekge M.M.; Radionuclide Therapy of Skin Cancers and Bowen\u2019s Disease Using A Specially Designed Rhenium Cream. Reference Module in Biomedical Sciences 2021,B9780128229606000000","journal-title":"Reference Module in Biomedical Sciences"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s13346-020-00823-3","volume":"11","author":"Parhi R.","year":"2021","unstructured":"Parhi R.; Mandru A.; Enhancement of skin permeability with thermal ablation techniques: concept to commercial products. Drug Deliv Transl Res 2021,11(3),817-841","journal-title":"Drug Deliv Transl Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12247-020-09460-2","volume":"16","author":"Halder J.","year":"2021","unstructured":"Halder J.; Gupta S.; Kumari R.; Gupta G.D.; Rai V.K.; Microneedle array: applications, recent advances, and clinical pertinence in transdermal drug delivery. J Pharm Innov 2021,16(3),558-565","journal-title":"J Pharm Innov"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijpharm.2018.10.043","volume":"553","author":"Ruan W.","year":"2018","unstructured":"Ruan W.; Zhai Y.; Yu K.; Wu C.; Xu Y.; Coated microneedles mediated intradermal delivery of octaarginine\/BRAF siRNA nanocomplexes for anti-melanoma treatment. Int J Pharm 2018,553(1-2),298-309","journal-title":"Int J Pharm"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1007\/s13346-020-00735-2","volume":"10","author":"Cheng Z.","year":"2020","unstructured":"Cheng Z.; Lin H.; Wang Z.; Yang X.; Zhang M.; Liu X.; Wang B.; Wu Z.; Chen D.; Preparation and characterization of dissolving hyaluronic acid composite microneedles loaded micelles for delivery of curcumin. Drug Deliv Transl Res 2020,10(5),1520-1530","journal-title":"Drug Deliv Transl Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.msec.2019.02.095","volume":"99","author":"Ahmed K.S.","year":"2019","unstructured":"Ahmed K.S.; Shan X.; Mao J.; Qiu L.; Chen J.; Derma roller&#xAE; microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Mater Sci Eng C 2019,99,1448-1458","journal-title":"Mater Sci Eng C"},{"key":"ref=78","doi-asserted-by":"publisher","DOI":"10.1201\/9780203909683.ch6","author":"Vanbever R.","year":"2002","unstructured":"Vanbever R.; Preat V.; Skin electroporation for transdermal and topical drug delivery. Transdermal Drug Delivery Systems 2002","journal-title":"Transdermal Drug Delivery Systems"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-19-0972","volume":"26","author":"Bhatia S.","year":"2020","unstructured":"Bhatia S.; Longino N.V.; Miller N.J.; Kulikauskas R.; Iyer J.G.; Ibrani D.; Blom A.; Byrd D.R.; Parvathaneni U.; Twitty C.G.; Campbell J.S.; Le M.H.; Gargosky S.; Pierce R.H.; Heller R.; Daud A.I.; Nghiem P.; Intratumoral delivery of plasmid il12 via electroporation leads to regression of injected and noninjected tumors in merkel cell carcinoma. Clin Cancer Res 2020,26(3),598-607","journal-title":"Clin Cancer Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10396-021-01131-0","volume":"48","author":"Feril L.B.","year":"2021","unstructured":"Feril L.B.; Yamaguchi K.; Ikeda-Dantsuji Y.; Furusawa Y.; Tabuchi Y.; Takasaki I.; Ogawa R.; Cui Z.G.; Tachibana K.; Low-intensity ultrasound inhibits melanoma cell proliferation in vitro and tumor growth in vivo. J Med Ultrason 2021,48(4),451-461","journal-title":"J Med Ultrason"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"108056","DOI":"10.1016\/j.apacoust.2021.108056","volume":"179","author":"Yang D.","year":"2021","unstructured":"Yang D.; Zhang Q.; Zhang Z.; Yuan Z.; Xu G.; Wu J.; Zhang M.; Guo X.; Tu J.; Zhang D.; The influence of ultrasound-induced microbubble cavitation on the viability, migration and cell cycle distribution of melanoma cells. Appl Acoust 2021,179,108056","journal-title":"Appl Acoust"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12935-020-01616-x","volume":"20","author":"Khorsandi K.","year":"2020","unstructured":"Khorsandi K.; Hosseinzadeh R.; Chamani E.; Molecular interaction and cellular studies on combination photodynamic therapy with rutoside for melanoma A375 cancer cells: an in vitro study. Cancer Cell Int 2020,20(1),525","journal-title":"Cancer Cell Int"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1088\/0031-9155\/61\/7\/R57","volume":"61","author":"Pogue B.W.","year":"2016","unstructured":"Pogue B.W.; Elliott J.T.; Kanick S.C.; Davis S.C.; Samkoe K.S.; Maytin E.V.; Pereira S.P.; Hasan T.; Revisiting photodynamic therapy dosimetry: reductionist","journal-title":"Phys Med Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"101680","DOI":"10.1016\/j.pdpdt.2020.101680","volume":"30","author":"Garcia M.R.","year":"2020","unstructured":"Garcia M.R.; Requena M.B.; Pratavieira S.; Moriyama L.T.; Becker M.; Bagnato V.S.; Kurachi C.; Magalh&#xE3;es D.V.; Development of a system to treat and online monitor photodynamic therapy of skin cancer using PpIX near-infrared fluorescence. Photodiagn Photodyn Ther 2020,30,101680","journal-title":"Photodiagn Photodyn Ther"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"105056","DOI":"10.1016\/j.ejps.2019.105056","volume":"139","author":"Reis T.A.","year":"2019","unstructured":"Reis T.A.; Jaculi A.E.; Ramos K.L.V.; Souza P.E.N.; Veiga S.F.H.; Joanitti G.A.; Azevedo R.B.; Gratieri T.; Cunha F.M.; Gelfuso G.M.; Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy. Eur J Pharm Sci 2019,139,105056","journal-title":"Eur J Pharm Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.bbamem.2009.08.015","volume":"1788","author":"Karande P.","year":"2009","unstructured":"Karande P.; Mitragotri S.; Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta Biomembr 2009,1788(11),2362-2373","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=87","first-page":"07","author":"Angamuthu M.","year":"2017","unstructured":"Angamuthu M.; Ainampudi S.; Role of physical, chemical percutaneous penetration enhancement methods: A concise review. J Nanomed Biotherapeutic Discov 2017,07","journal-title":"J Nanomed Biotherapeutic Discov"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.xphs.2017.10.039","volume":"107","author":"Dante M.C.L.","year":"2018","unstructured":"Dante M.C.L.; Borgheti C.L.N.; Fantini M.C.A.; Pra&#xE7;a F.S.G.; Medina W.S.G.; Pierre M.B.R.; Lara M.G.; Liquid Crystalline systems based on glyceryl monooleate and penetration enhancers for skin delivery of celecoxib: characterization, in vitro drug release, and in vivo studies. J Pharm Sci 2018,107(3),870-878","journal-title":"J Pharm Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/pharmaceutics12111078","volume":"12","author":"Tampucci S.","year":"2020","unstructured":"Tampucci S.; Guazzelli L.; Burgalassi S.; Carpi S.; Chetoni P.; Mezzetta A.; Nieri P.; Polini B.; Pomelli C.S.; Terreni E.; Monti D.; pH-Responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy. Pharmaceutics 2020,12(11),1078","journal-title":"Pharmaceutics"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"102804","DOI":"10.1016\/j.jddst.2021.102804","volume":"66","author":"Nair A.","year":"2021","unstructured":"Nair A.; Nair S.C.; Banerji A.; Biswas R.; Mony U.; Development and evaluation of plumbagin loaded chitin hydrogel for the treatment of skin cancer. J Drug Deliv Sci Technol 2021,66,102804","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.2174\/1381612826666200819202821","volume":"26","author":"Lalotra A.S.","year":"2020","unstructured":"Lalotra A.S.; Singh V.; Khurana B.; Agrawal S.; Shrestha S.; Arora D.; A comprehensive review on nanotechnology-based innovations in topical drug delivery for the treatment of skin cancer. Curr Pharm Des 2020,26(44),5720-5731","journal-title":"Curr Pharm Des"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.2174\/1381612826666200826140448","volume":"26","author":"Jain R.","year":"2020","unstructured":"Jain R.; Sarode I.; Singhvi G.; Dubey S.K.; Nanocarrier based topical drug delivery- A promising strategy for treatment of skin cancer. Curr Pharm Des 2020,26(36),4615-4623","journal-title":"Curr Pharm Des"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/1568026621666210701144124","volume":"21","author":"Nasir A.","year":"2021","unstructured":"Nasir A.; Khan A.; Li J.; Naeem M.; Khalil A.A.K.; Khan K.; Qasim M.; Nanotechnology, a tool for diagnostics and treatment of cancer. Curr Top Med Chem 2021,21(15),1360-1376","journal-title":"Curr Top Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jscs.2012.12.009","volume":"18","author":"Safari J.","year":"2014","unstructured":"Safari J.; Zarnegar Z.; Advanced drug delivery systems: Nanotechnology of health design A review. J Saudi Chem Soc 2014,18(2),85-99","journal-title":"J Saudi Chem Soc"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"131556","DOI":"10.1016\/j.molstruc.2021.131556","volume":"1249","author":"Gulla S.","year":"2022","unstructured":"Gulla S.; Reddy V.C.; Araveti P.B.; Lomada D.; Srivastava A.; Reddy M.C.; Reddy K.R.; Synthesis of Titanium Dioxide Nanotubes (TNT) conjugated with quercetin and its in vivo antitumor activity against skin cancer. J Mol Struct 2022,1249,131556","journal-title":"J Mol Struct"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.2174\/156802662030201110091740","volume":"20","author":"Yadollahpour A.","year":"2020","unstructured":"Yadollahpour A.; Nanotechnology in targeted drug delivery in medical theranostics: from lab to bed. Curr Top Med Chem 2020,20(30),2735-2736","journal-title":"Curr Top Med Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41598-020-67349-z","volume":"10","author":"Abdel F.D.A.","year":"2020","unstructured":"Abdel F.D.A.; Kamel R.; Fadel M.; PEGylated lipid nanocarrier for enhancing photodynamic therapy of skin carcinoma using curcumin: In-vitro\/in-vivo studies and histopathological examination. Sci Rep 2020,10(1),10435","journal-title":"Sci Rep"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"17041","DOI":"10.1039\/C9NR06303J","volume":"11","author":"Lio D.C.S.","year":"2019","unstructured":"Lio D.C.S.; Liu C.; Oo M.M.S.; Wiraja C.; Teo M.H.Y.; Zheng M.; Chew S.W.T.; Wang X.; Xu C.; Transdermal delivery of small interfering RNAs with topically applied mesoporous silica nanoparticles for facile skin cancer treatment. Nanoscale 2019,11(36),17041-17051","journal-title":"Nanoscale"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2106682","DOI":"10.1002\/adma.202106682","volume":"34","author":"Lai X.","year":"2022","unstructured":"Lai X.; Liu X.L.; Pan H.; Zhu M.H.; Long M.; Yuan Y.; Zhang Z.; Dong X.; Lu Q.; Sun P.; Lovell J.F.; Chen H.Z.; Fang C.; Light\u2010triggered efficient sequential drug delivery of biomimetic nanosystem for multimodal chemo\u2010, antiangiogenic, and anti\u2010mdsc therapy in melanoma. Adv Mater 2022,34(10),2106682","journal-title":"Adv Mater"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/jbm.a.37333","volume":"110","author":"Wei W.","year":"2022","unstructured":"Wei W.; Zarghami N.; Abasi M.; Ertas Y.N.; Pilehvar Y.; Implantable magnetic nanofibers with ON-OFF switchable release of curcumin for possible local hyperthermic chemotherapy of melanoma. J Biomed Mater Res A 2022,110(4),851-860","journal-title":"J Biomed Mater Res A"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.jddst.2019.101147","volume":"53","author":"Preet S.","year":"2019","unstructured":"Preet S.; Pandey S.K.; Kaur K.; Chauhan S.; Saini A.; Gold nanoparticles assisted co-delivery of nisin and doxorubicin against murine skin cancer. J Drug Deliv Sci Technol 2019,53,101147","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijbiomac.2022.01.062","volume":"201","author":"Yoong W.C.","year":"2022","unstructured":"Yoong W.C.; Loke C.F.; Juan J.C.; Yusoff K.; Mohtarrudin N.; Tatsuma T.; Xu Y.; Lim T.H.; Alginate-enabled green synthesis of S\/Ag1.93S nanoparticles, their photothermal property and in-vitro assessment of their anti-skin-cancer effects augmented by a NIR laser. Int J Biol Macromol 2022,201,516-527","journal-title":"Int J Biol Macromol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"11936","DOI":"10.1021\/acsnano.8b03007","volume":"12","author":"Tham H.P.","year":"2018","unstructured":"Tham H.P.; Xu K.; Lim W.Q.; Chen H.; Zheng M.; Thng T.G.S.; Venkatraman S.S.; Xu C.; Zhao Y.; Microneedle-assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma. ACS Nano 2018,12(12),11936-11948","journal-title":"ACS Nano"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/10717544.2021.1898703","volume":"28","author":"Song M.","year":"2021","unstructured":"Song M.; Xia W.; Tao Z.; Zhu B.; Zhang W.; Liu C.; Chen S.; Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy. Drug Deliv 2021,28(1),594-606","journal-title":"Drug Deliv"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/gels7040230","volume":"7","author":"Md S.","year":"2021","unstructured":"Md S.; Alhakamy N.A.; Neamatallah T.; Alshehri S.; Mujtaba M.A.; Riadi Y.; Radhakrishnan A.K.; Khalilullah H.; Gupta M.; Akhter M.H.; Development, characterization, and evaluation of &#x3B1;-mangostin-loaded polymeric nanoparticle gel for topical therapy in skin cancer. Gels 2021,7(4),230","journal-title":"Gels"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1021\/acsanm.9b01924","volume":"2","author":"Capanema N.S.V.","year":"2019","unstructured":"Capanema N.S.V.; Carvalho I.C.; Mansur A.A.P.; Carvalho S.M.; Lage A.P.; Mansur H.S.; Hybrid hydrogel composed of carboxymethylcellulose-silver nanoparticles-doxorubicin for anticancer and antibacterial therapies against melanoma skin cancer cells. ACS Appl Nano Mater 2019,2(11),7393-7408","journal-title":"ACS Appl Nano Mater"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1021\/acs.molpharmaceut.8b00047","volume":"15","author":"Safwat M.A.","year":"2018","unstructured":"Safwat M.A.; Soliman G.M.; Sayed D.; Attia M.A.; Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model. Mol Pharm 2018,15(6),2194-2205","journal-title":"Mol Pharm"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijbiomac.2021.03.122","volume":"181","author":"Akhter K.F.","year":"2021","unstructured":"Akhter K.F.; Mumin M.A.; Lui E.M.K.; Charpentier P.A.; Transdermal nanotherapeutics: Panax quinquefolium polysaccharide nanoparticles attenuate UVB-induced skin cancer. Int J Biol Macromol 2021,181,221-231","journal-title":"Int J Biol Macromol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"119705","DOI":"10.1016\/j.ijpharm.2020.119705","volume":"587","author":"Imran M.","year":"2020","unstructured":"Imran M.; Iqubal M.K.; Imtiyaz K.; Saleem S.; Mittal S.; Rizvi M.M.A.; Ali J.; Baboota S.; Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer. Int J Pharm 2020,587,119705","journal-title":"Int J Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.eurpolymj.2019.08.001","volume":"119","author":"Rengifo A.F.C.","year":"2019","unstructured":"Rengifo A.F.C.; Stefanes N.M.; Toigo J.; Mendes C.; Argenta D.F.; Dotto M.E.R.; Santos da Silva M.C.; Nunes R.J.; Caon T.; Parize A.L.; Minatti E.; PEO-chitosan nanofibers containing carboxymethyl-hexanoyl chitosan\/dodecyl sulfate nanoparticles loaded with pyrazoline for skin cancer treatment. Eur Polym J 2019,119,335-343","journal-title":"Eur Polym J"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08982104.2019.1604746","volume":"30","author":"Marwah M.","year":"2020","unstructured":"Marwah M.; Perrie Y.; Badhan R.K.S.; Lowry D.; Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer. J Liposome Res 2020,30(2),136-149","journal-title":"J Liposome Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11095-021-02999-w","volume":"38","author":"Do Reis S.R.R.","year":"2021","unstructured":"Do Reis S.R.R.; Helal N.E.; Da Silva De Barros A.O.; Pinto S.R.; Portilho F.L.; De Oliveira S.L.B.; Alencar L.M.R.; Dahoumane S.A.; Alexis F.; Ricci J.E.; Santos O.R.; Dual encapsulated dacarbazine and zinc phthalocyanine polymeric nanoparticle for photodynamic therapy of melanoma. Pharm Res 2021,38(2),335-346","journal-title":"Pharm Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.arabjc.2017.07.010","volume":"13","author":"Priya P.","year":"2020","unstructured":"Priya P.; Mohan Raj R.; Vasanthakumar V.; Raj V.; Curcumin-loaded layer-by-layer folic acid and casein coated carboxymethyl cellulose\/casein nanogels for treatment of skin cancer. Arab J Chem 2020,13(1),694-708","journal-title":"Arab J Chem"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026622666220902104906","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208448\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026622666220902104906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:10:02Z","timestamp":1678709402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208448\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026622666220902104906","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}